ZJ9-16494-04706 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-26
Dose 1 — Pfizer-BioNTech
2021-08-29
Registered in v-safe
2021-08-29
Survey response — days 1–6 daily, dose 1
MedDRA: Dysgeusia — Feeling: Good · Site: Itching · Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Metallic taste in mouth

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Nausea

Adult check-in
2021-08-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-09-02
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-09-11
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-11-25
Health check-in — 3 months, dose 1
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-26	Pfizer-BioNTech	No

Free text

Release 9 — days 1–6 daily, dose 1

2021-08-29

Systemic reaction (other): Metallic taste in mouth

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Dysgeusia	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release